Skip to main content
Alan Venook, MD, Oncology, San Francisco, CA

AlanP.VenookMD

Oncology San Francisco, CA

Gastrointestinal Cancer, Hematologic Oncology

Professor of Medicine, UCSF

Dr. Venook is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Venook's full profile

Already have an account?

  • Office

    1600 Divisadero St
    San Francisco, CA 94143
    Phone+1 415-353-9888
    Fax+1 415-353-7150

Summary

  • Dr. Alan Venook is a nationally renowned expert in colorectal and liver cancers at the UCSF Helen Diller Family Comprehensive Cancer Center where he leads the Gastrointestinal Oncology program. In his research, he focuses on treating liver tumors with directed approaches, including infusional chemotherapy and biological agents.

    Venook earned a medical degree at UCSF in 1980. He spent two years in the Public Health Service following an internship in internal medicine at UCSF. He completed a residence in internal medicine at the University of California, Davis and a fellowship in hematology and oncology at UCSF. Venook, who has been on the medical staff at UCSF since 1988, is a professor of medicine in hematology and oncology.

Education & Training

  • University of California (San Francisco)
    University of California (San Francisco)Fellowship, Hematology and Medical Oncology, 1985 - 1988
  • University of California Davis Health
    University of California Davis HealthResidency, Internal Medicine, 1983 - 1985
  • University of California San Francisco School of Medicine
    University of California San Francisco School of MedicineClass of 1980

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1981 - 2026
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2009-2014
  • America's Top Doctors for Cancer Castle Connolly, 2005-2013
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Association of Coffee Intake with Survival in Patients with Advanced or Metastatic Colorectal Cancer  
    I-Wen Chang, Charles D Blanke, Alan P Venook, Richard M Goldberg, Jeffrey A Meyerhardt, Kimmie Ng, JAMA Oncology
  • Identification of a Genomic Region Between SLC29A1 and HSP90AB1 Associated with Risk of Bevacizumab-Induced Hypertension: CALGB 80405 (Alliance)  
    Hope S Rugo, Bryan P Schneider, Alan Venook, Clinical Cancer Research

Other

Press Mentions

  • KRAS Inhibitors in Pancreatic Cancer: Hope on the Horizon?
    KRAS Inhibitors in Pancreatic Cancer: Hope on the Horizon?September 9th, 2024
  • Clinical Controversy: Watch-and-Wait or Surgery in Rectal Cancer near Complete Responders?
    Clinical Controversy: Watch-and-Wait or Surgery in Rectal Cancer near Complete Responders?August 20th, 2024
  • CRC in Middle Age Linked to Morning Sickness Pill from 60s, 70s
    CRC in Middle Age Linked to Morning Sickness Pill from 60s, 70sMarch 19th, 2023
  • Join now to see all

Grant Support

  • Data Safety MonitoringNational Cancer Institute2007–2011
  • C98-118-01: Sch58500 &Chemotherapy In Colorectal Cancer Metastatic To LiverNational Center For Research Resources2000–2002
  • Core--Clinical Research Support ServicesNational Cancer Institute1999–2002
  • Cancer And Leukemia Group BNational Cancer Institute1995–2002